A Study to Evaluate the Effect of Renal Impairment on JNJ-64417184 and Its Two Minor Metabolites JNJ-68294291 and JNJ-65201526 in Adult Participants

NCT04426357 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Stopped company decision

Conditions

Renal Impairment

Interventions

DRUG: JNJ-64417184

Sponsor

Janssen Pharmaceutica N.V., Belgium